gastroenterologist

In short, Renflexis is a biosimilar infusion medication that blocks TNF-alpha to reduce inflammation in moderate to severe Crohn’s disease. The treatment involves intravenous infusions administered initially at specific intervals, then every eight weeks for maintenance. Regular monitoring during Renflexis therapy ensures safety and effectiveness while managing potential side effects. Understanding Crohn’s Disease Crohn’s disease

Read More